Results 51 to 60 of about 150,928 (204)

Temozolomide combined with irinotecan regresses a cisplatinum-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) precision-oncology mouse model. [PDF]

open access: yes, 2017
Relapsed osteosarcoma is a recalcitrant tumor. A patient's cisplatinum (CDDP)-resistant relapsed osteosarcoma lung metastasis was previously established orthotopically in the distal femur of mice to establish a patient-derived orthotopic xenograft (PDOX)
Dry, Sarah M.   +23 more
core   +1 more source

Soft Tissue Sarcomas

open access: yesAnnals of Surgery, 1975
One hundred fifty-five adult patients with "operable" soft part sarcomas including rhabdomyosarcoma, liposarcoma, leiomyosarcoma and fibrosarcoma of the trunk and extremities are reviewed. Local recurrences of 93% and 60% occurred after local and wide excisions of the primary tumor.
R E, Gerner, G E, Moore, J W, Pickren
openaire   +3 more sources

Retroperitoneal intramuscular haemangioma: Imaging features. [PDF]

open access: yes, 2010
Retroperitoneal intramuscular haemangiomas are quite rare. Interruption of the muscle layer by intramuscular cavernous haemangioma raised the suspicion of a soft tissue sarcoma.
Ab. Hamid, Suzana, Hassan, H. A.
core  

Long-term renal function and hypertension in adult survivors of childhood sarcoma [PDF]

open access: yes, 2018
Aim: Little data is available on long-term renal impairment in survivors from childhood sarcoma. We investigated the prevalence of renal impairment and hypertension after very long-term follow-up in survivors who reached adulthood after treatment for ...
Andreoli, Gianmarco   +6 more
core   +1 more source

Systemic inflammation index is a predictive and prognostic factor in patients with liposarcoma or leiomyosarcoma treated with trabectedin

open access: yesScientific Reports
Trabectedin is a chemotherapeutic agent that has shown activity in the treatment of patients with soft tissue sarcomas after failure of anthracycline-based therapy and the best results were recorded in the treatment of L-sarcomas.
Pawel Sobczuk   +9 more
doaj   +1 more source

Chemotherapy Strategies and Their Efficacy for Mesenchymal Chondrosarcoma

open access: yesCurrent Oncology
Mesenchymal chondrosarcoma (MCS) is characterised by small round cell biology, frequent HEY1-NCOA2 fusion, and high vascularity. These features plausibly lessen extracellular matrix barriers and confer relative chemosensitivity.
Piotr Remiszewski   +4 more
doaj   +1 more source

Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma. [PDF]

open access: yes, 2014
Background. Extraskeletal osteosarcoma (ESOS) is a rare subtype of osteosarcoma. We investigated patient characteristics, overall survival, and prognostic factors in ESOS. Methods.
Boscardin, W John   +4 more
core   +2 more sources

Lymphadenectomy in the treatment of sarcomas – indications and technique

open access: yesOncology Reviews
Sarcomas are a rare type of malignancy with limited treatment options so far. This analysis aimed to describe the impact of lymphadenectomy on treating sarcoma patients. Sarcomas characterized by lymphatic spread are rare.
Piotr Dunaj   +10 more
doaj   +1 more source

iCREATE: imaging features of primary and metastatic alveolar soft part sarcoma from the EORTC CREATE study

open access: yesCancer Imaging, 2020
Background Alveolar Soft Part Sarcoma (ASPS) is a rare, slow-growing, but highly vascular soft tissue sarcoma, characterised by a high rate of metastases at presentation.
Naami Charlotte Mcaddy   +5 more
doaj   +1 more source

Accuration of Fine Needle Aspiration Biopsy in Musculoskeletal Tumour [PDF]

open access: yes, 2016
Fine needle aspiration biopsy (FNAB) has been reported to be the preferable choice of biopsy for musculoskeletal tumour. While FNAB appears to have advantages to core biopsy in the aspect of simplicity and cost, the diagnostic accuracy should be the most
Dewo, P. (Punto)   +3 more
core   +3 more sources

Home - About - Disclaimer - Privacy